High-Density Lipoprotein Lipidomics in Chronic Kidney Disease
Clinical Chemistry · 01.03.2023 · 69 (3) · 273-282
DOI: 10.1093/clinchem/hvac216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry, online erschienen am 16.01.2023. Verfasst von Benjamin Lidgard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, USA. Hauptthemen laut MEDLINE: Albuminuria, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Patients with chronic kidney disease (CKD) have dysfunctional high-density lipoprotein (HDL) particles as compared with the general population. Understanding the lipid composition of HDL may provide mechanistic insight. We tested associations of estimated glomerular filtration rate (eGFR) and albuminuria with relative HDL abundance of ceramides, sphingomyelins, and phosphatidylcholines in participants with CKD.
Methods
We studied 490 participants with CKD from the Seattle Kidney Study. HDL was isolated from plasma; targeted lipidomics was used to quantify the relative abundance of ceramides, sphingomyelins, and phosphatidylcholines per 10 µg of total HDL protein. We evaluated the associations of eGFR and albuminuria with levels of individual lipids and lipid classes (including 7 ceramides, 6 sphingomyelins, and 24 phosphatidylcholines) using multivariable linear regression, controlling for multiple comparisons via the false discovery rate.
Results
The mean (SD) eGFR was 45 (24) mL/min/1.73 m2; the median (IQR[interquartile range]) albuminuria was 108 (16, 686) mg/g (12.2 [1.8, 77.6] mg/mmol) urine creatinine. After adjusting for demographics, past medical history, laboratory values, and medication use, eGFR was not associated with higher relative abundance of any class of lipids or individual lipids. Greater albuminuria was significantly associated with a higher relative abundance of total ceramides and moderate–long R-chain sphingomyelins, ceramides 22:0 and 24:1, hexosylceramide 16:0, sphingomyelin 16:0, and phosphatidylcholines 29:0, 30:1, and 38:2; the strongest association was for hexosylceramide 16:0 (increase per doubling of urine albumin to creatinine ratio 0.022 (95% CI, 0.012–0.032).
Conclusions
Greater albuminuria was significantly associated with specific alterations in the lipid composition of HDL in participants with CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Washington, Seattle, USA.
- Department of Laboratory Medicine & Pathology, University of Washington, Seattle, USA.
- Department of Epidemiology, University of Washington, Seattle, USA.
- Department of Medicine, Vanderbilt University, Nashville, USA.
ORCID-Profile: Benjamin Lidgard, Andrew N Hoofnagle, Cassianne Robinson-Cohen
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Lidgard, B., Hoofnagle, A. N., Zelnick, L. R., de Boer, I. H., Fretts, A. M., Kestenbaum, B. R., Lemaitre, R. N., Robinson-Cohen, C., & Bansal, N. (2023). High-Density Lipoprotein Lipidomics in Chronic Kidney Disease. Clinical Chemistry, 69(3), 273-282. https://doi.org/10.1093/clinchem/hvac216
Vancouver
Lidgard B, Hoofnagle AN, Zelnick LR, de Boer IH, Fretts AM, Kestenbaum BR, et al. High-Density Lipoprotein Lipidomics in Chronic Kidney Disease. Clinical Chemistry. 2023;69(3):273-282. doi:10.1093/clinchem/hvac216
BibTeX
@article{Lidgard2023,
author = {Lidgard, Benjamin and Hoofnagle, Andrew N and Zelnick, Leila R and de Boer, Ian H and Fretts, Amanda M and Kestenbaum, Bryan R and Lemaitre, Rozenn N and Robinson-Cohen, Cassianne and Bansal, Nisha},
title = {High-Density Lipoprotein Lipidomics in Chronic Kidney Disease},
journal = {Clinical Chemistry},
year = {2023},
volume = {69},
number = {3},
pages = {273--282},
doi = {10.1093/clinchem/hvac216}
}
EUVIMED